Delving into NASDAQ:VYGR's Growth Prospects.

Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) is suited for growth investing. Investors should of course do their own research, but we spotted VOYAGER THERAPEUTICS INC showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.

Highlighting Notable Growth Metrics of NASDAQ:VYGR.

• With a favorable Return on Equity (ROE) of 55.98%, VOYAGER THERAPEUTICS INC demonstrates its ability to deliver attractive returns for shareholders. This metric highlights the company's effective management of assets and its profitability.
• With a track record of beating EPS estimates in the last 4 quarters, VOYAGER THERAPEUTICS INC showcases its consistent ability to deliver earnings surprises. This reflects the company's strong execution and its competitive position in the market.
• VOYAGER THERAPEUTICS INC has achieved significant 1-year revenue growth of 510.0%, signaling its ability to capture market opportunities and drive top-line expansion. This growth indicates the company's effective execution and its potential for continued success.
• With consistent quarter-to-quarter (Q2Q) revenue growth of 6.0K%, VOYAGER THERAPEUTICS INC exemplifies its ability to generate increased sales and revenue streams. This growth signifies the company's strong business performance and its potential for continued growth.
• The operating margin of VOYAGER THERAPEUTICS INC has seen steady growth over the past year, signaling improved profitability. This trend indicates the company's effective cost management and its ability to generate higher returns.
• With positive growth in its free cash flow (FCF) over the past year, VOYAGER THERAPEUTICS INC showcases its ability to generate strong cash flows and maintain a solid financial position. This growth reflects the company's efficient utilization of capital and its commitment to long-term value creation.
• VOYAGER THERAPEUTICS INC has demonstrated consistent growth in its earnings per share (EPS) from one quarter to another (Q2Q), with a 305.0% increase. This indicates improving financial performance and the company's effective management of its operations.
• VOYAGER THERAPEUTICS INC has seen a 33.4% change in the average next Quarter EPS Estimate by analysts over the last 3 months, signaling the shifting perception of the company's EPS outlook.
• The quarterly earnings of VOYAGER THERAPEUTICS INC have shown a 305.0% increase compared to the previous quarter, as revealed in the recent financial report. This growth signifies positive momentum in the company's financials, pointing towards a promising upward trend
• accelerating EPS growth for VOYAGER THERAPEUTICS INC: the current Q2Q growth of 305.0% exceeds the previous year Q2Q growth of -507.0%.

How does the complete fundamental picture look for NASDAQ:VYGR?

ChartMill utilizes a proprietary algorithm to assign a Fundamental Rating to every stock. This rating, ranging from 0 to 10, is computed daily by analyzing a variety of fundamental indicators and properties.

Taking everything into account, VYGR scores 6 out of 10 in our fundamental rating. VYGR was compared to 592 industry peers in the Biotechnology industry. VYGR has an excellent financial health rating, but there are some minor concerns on its profitability. VYGR has a correct valuation and a medium growth rate.

Our latest full fundamental report of VYGR contains the most current fundamental analsysis.

Our Lois Navellier screen will find you more ideas suited for growth investing.

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.